Real-world 5-year survival outcomes with durvalumab after chemoradiotherapy in unresectable, stage III NSCLC: Final data extraction from PACIFIC-R

Nicolas Girard*, Jair Bar, Christoph Daniel, John Field, Rainer Fietkau, Marina C. Garassino, Pilar Garrido Lopez, Vilde D. Haakensen, Jeroen T. Hiltermann, Steven C. Kao, Fiona McDonald, Francoise Mornex, Mor T. Moskovitz, Solange Peters, Shankar Siva, Ben Solomon, Yao Qiao, Shawn Anand, Pratibha Chander, Andrea Riccardo Filippi

*Corresponding author for this work

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - Mar-2025
EventEuropean Lung Cancer Congress 2025 - Paris, France
Duration: 26-Mar-202529-Mar-2025
https://www.esmo.org/meeting-calendar/european-lung-cancer-congress-2025

Conference

ConferenceEuropean Lung Cancer Congress 2025
Abbreviated titleELCC 2025
Country/TerritoryFrance
CityParis
Period26/03/202529/03/2025
Internet address

Cite this